首页 News 正文

[Phase III clinical success of Eli Lilly ultra long-acting insulin] Eli Lilly announced that the weekly injection of ultra long-acting insulin Insulin Efstora Alfa in the treatment of type II diabetes, two phase III clinical QWINT-2 and QWINT-4, obtained positive data.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

六月清晨搅 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    30